Aric Swancutt
Primary Podiatric Medicine · Palm Beach Gardens, FLNPI 1184252512
Payments from drug & device makers
What this record shows
Stryker accounts for 64.8% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $1,924 and has fallen 60.8% since, to $754 in 2025.
Across 36 payments — averaging $81.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Linvatec Corporation$445
- Biotissue Holdings Inc.$156
- Abbott$142
- Smith+Nephew$87
- Treace Medical Concepts, Inc.$37
- plus $171 from 8 others
What the payments were for
- Travel & lodging$1,64056%
- Food & beverage$1,31044%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 15 | $1,910 |
| Linvatec Corporation | 4 | $445 |
| Biotissue Holdings Inc. | 2 | $156 |
| Abbott | 2 | $142 |
| Smith+Nephew | 2 | $87 |
| Treace Medical Concepts, Inc. | 2 | $37 |
| Johnson & Johnson | 1 | $34 |
| Paratek Pharmaceuticals, Inc. | 2 | $31 |
| Cashflow Solutions, LLC | 1 | $20 |
| Bioventus LLC | 1 | $20 |
| Organogenesis Inc. | 1 | $19 |
| Trice Medical, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Kerecis Limited | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROstep$1,187
- BioBrace 23mm$344
- COLINK AFX$344
- QUANTUM$344
- INFINITY$255
- INVISION$147
- GRAVITY SYNCHFIX$147
- INBONE$147
- PROPHECY$140
- VARIAX$134
- Diamondback Peripheral$122
How this compares
$2,949 in reported general payments places this provider in the 75th percentile of 68 primary podiatric medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 58 | $908 |
| Doxycycline Hyclate | 138 | $744 |
| Mupirocin | 112 | $712 |
| Gentamicin Sulfate | 23 | $628 |
| Ammonium Lactate | 31 | $569 |
| Methylprednisolone | 25 | $169 |
| Ketoconazole | 11 | $159 |
| Ciprofloxacin Hcl | 16 | $124 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $111 |
| Meloxicam | 20 | $14 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Palm Beach Gardens
- Melissa CohenPalm Beach Gardens$28
- Robert SnyderTamarac$623K
- Melissa VerdeLongwood$257K
- Kevin LapoffGreenacres$64K
- Beth PearceSt Augustine$27K
- Dmitry SandlerHialeah$11K
- Richard MercadoMiami$10K
- Gladys de LeonOrlando$8K
- Tanika HarlisPort Saint Lucie$6K
- Liana SeldinCoral Gables$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.